← Open Payments lookup

DOUGLAS WATSON: Open Payments

NPI 1770211658 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,922 in 102 payments from 14 companies in 2025. Trend: 2023 $986 · 2024 $1,906 · 2025 $1,922

Food & beverage: $1,922
CompanyPaymentsAmount
ABBVIE INC.29$521
Axsome Therapeutics, Inc.9$322
Alkermes, Inc.19$238
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$231
Teva Pharmaceuticals USA, Inc.3$159
Vanda Pharmaceuticals Inc.8$149
Otsuka America Pharmaceutical, Inc.6$102
Lundbeck LLC2$42
Janssen Pharmaceuticals, Inc2$36
Supernus Pharmaceuticals, Inc.2$35

Products named: VRAYLAR, Auvelity, CAPLYTA, ARISTADA, UZEDY, HETLIOZ, REXULTI, LYBALVI.

Industry payments across IN — which companies pay providers there.